uBiome Launches Innovation Challenge to Advance Microbiome Clinical Outcomes Research

Posted by: | October 11, 2018 | Comments

Submissions to the uBiome Clinical Outcomes in Microbial Genomics Innovation Challenge are now open, welcoming applications from healthcare providers, students, trainees, and researchers worldwide. Winning proposals will receive grants which include access to uBiome’s clinical testing kits, as well as microbiome sequencing and bioinformatics services.

“uBiome is thrilled to further expand our collaborations in the clinical space as we underscore the microbiome’s impact on clinical decision-making,” said uBiome’s CEO, Jessica Richman, PhD. “Given the microbiome’s association with nearly all aspects of health, discovering new therapeutic targets for areas of high disease burden should motivate a wide diversity of interesting projects.”

The microbiome is made up of trillions of microorganisms living in and on varying sites of the body that may impact every organ system, and the availability of at-home clinical microbiome testing makes robust clinical research of the microbiome more accessible. Microbes in the gut may play a critical role in human health and have been linked to many chronic health problems, including autoimmune, cardiovascular, metabolic, neurologic, and mental health disorders. The vaginal microbiome plays an important role in vaginal and cervical health, transmission of disease, and in pregnancy and childbirth. Other body sites such as the skin, mouth and nose, have specialized microbial ecosystems as well.

Read more at: PR Web






Stay up-to-date!
Email Address *
First Name
Last Name

* indicates required
Privacy Policy




Terms & Conditions | Privacy Policy | © 2018 The Translational Microbiome Research Forum